menu
    • menu

    Company profile for NextCure

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NextCure is a fully integrated biotechnology company discovering and developing first-in-class immunotherapy-based biologics for cancer and other diseases. The company is focused on understanding biological pathways and leveraging our FIND-IOTM technology to discover, validate and build a proprietary pipeline. We believe identifying and targeting immune pathways will promote identification of effective targets for mediating s...
    NextCure is a fully integrated biotechnology company discovering and developing first-in-class immunotherapy-based biologics for cancer and other diseases. The company is focused on understanding biological pathways and leveraging our FIND-IOTM technology to discover, validate and build a proprietary pipeline. We believe identifying and targeting immune pathways will promote identification of effective targets for mediating sustained immunity leading to improved outcomes for cancer patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NextCureUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    NextCure, Inc. 9000 Virginia Manor Road Suite 200 Beltsville, MD 20705
    Telephone
    Telephone
    (240) 399-4900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nextcure.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nextcure To Present At Piper Sandler Healthcare Conference
    Nextcure To Present At Piper Sandler Healthcare Conference

    20 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/20/3191867/0/en/NextCure-to-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    20 Nov 2025
    Share Share
    NextCure Closes $21.5M PIPE Financing Before 2026 POC Data
    NextCure Closes $21.5M PIPE Financing Before 2026 POC Data

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189057/0/en/NextCure-Announces-Closing-of-21-5-Million-PIPE-Financing-in-Advance-of-First-Half-2026-Phase-1-POC-Data-Readouts.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    NextCure's $21.5M At-Market Common Stock Offering Under Nasdaq
    NextCure's $21.5M At-Market Common Stock Offering Under Nasdaq

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186222/0/en/NextCure-Announces-21-5-Million-Private-Placement-of-Common-Stock-Priced-at-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Nextcure Updates Business & Reports Q3 2025 Financials
    Nextcure Updates Business & Reports Q3 2025 Financials

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181955/0/en/NextCure-Provides-Business-Update-and-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Nextcure And Simcere Zaiming Expand Phase 1 Trial Of SIM0505
    Nextcure And Simcere Zaiming Expand Phase 1 Trial Of SIM0505

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167884/0/en/NextCure-and-Simcere-Zaiming-Announce-Expansion-of-Ongoing-Phase-1-Trial-of-SIM0505-CDH6-ADC-into-the-United-States.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    NextCure to Present at H.C. Wainwright Global Investment Conf
    NextCure to Present at H.C. Wainwright Global Investment Conf

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144318/0/en/NextCure-to-Present-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search